Tocainide

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C11H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 27DXO59SAN, chemically known as 2-amino-n-(2,6-dimethylphenyl)propionamid but more generally known as tocainide, which bears US NIH Compound Identifier 38945. European Medicines Agency schedules Tocainide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11136MIG. The term TOCAINIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules tocainide in its Anatomical Therapeutic Chemical (ATC) Classification. TOCAINIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule tocainide under HS 29242995 and SITC 51479. As of Q4 2014, TOCAINIDE remains US FDA's Preferred Term for this commodity. Tocainide bears US NLM identifiers UMLS ID C0085237 and NCI Concept Code C66607. SMILES: CC1=C(C(=CC=C1)C)NC(=O)C(C)N.